Replies to post #279881 on Avid Bioservices Inc (CDMO)

[cjgaddy]

Known Upcoming Events

Dec7: WCLC’16 - IASLC's 17th World Conf. on Lung Cancer, Vienna, Austria http://tinyurl.com/z8cq8vx
…2:30-3:45pm UTSW’s Dr. David Gerber to present addl. Biomarker data from Ph3.SUNRISE Trial: “A Pre-Treatment Serum Test Based on Complement & IL-10 Pathways Identifies Patients Benefiting from the Addition of Bavituximab to Docetaxel”

Dec8: 39th San Antonio Breast Cancer Symposium” http://tinyurl.com/zb5sopc
...Dr. Bruce Freimark(Dir.Res/Preclin.Oncology) poster: “PS-Targeting Enhances Anti-LAG3 in Murine Breast Cancer Tumors”

Dec12: FY'17Q2 (qe 10-31-16) Financials & Conf. Call - http://ir.peregrineinc.com/events.cfm

Dec11-15/Avid/Booth#209: IBC's Antibody Eng. & Therapeutics 2016”, SanDiego http://www.ibclifesciences.com/AntibodyEng/overview.xml

Jan24-26/Avid/Table#22: WCBP’17: 21st Symposium on Interface of Reg. & Analytical Sciences, WashDC http://www.casss.org/page/WCBP1700 (Theme: “Convergence & Harmonization”)

Feb20-22 2017: “CHI’s 5th Translational Models in Oncology & I-O”, SanFran http://www.triconference.com/Pre-Clinical-Oncology-Models
...Bruce Freimark(Dir.Res/Preclin.Oncology), “Blockade of PS-Mediated Tumor Immune Suppression to Enhance Immune Checkpoint Therapies”
.
.
= = = = = = = = = = = = = = = = = = = = =PRIOR:
Sep25-28: 2nd AACR-CRI Intl. Cancer Immunotherapy Conf., NYC http://tinyurl.com/hxtbdfm <=9-27-16/PR re: B019*: http://tinyurl.com/zy9yv78 (Bavi+PD1+LAG3 TNBC)
...Sep26 5:15-7:45pm: Michael J. Gray(PPHM Scientist) poster *B019, “LAG3 is an Immunotherapeutic Target in Murine Triple- Breast Cancers, Whose Activity is Significantly Enhanced in Combo with PS-Targeting Antibodies”
...Sep26 5:15-7:45pm: Dr. Raymond Birge(Rutgers) & PPHM poster B119, “Characterization of a PS, TAM Receptor (Tyro3, Axl, Mertk), PDL1 Axis in Breast Cancer”

Oct4-7/Avid/Booth#716: IBC's BioProcess Intl. Conf., Boston http://www.ibclifesciences.com/BPI/overview.xml & http://tinyurl.com/zyblds7
...10-5-16/8-8:30am: Peter Gagnon (Avid's VP/Process-Svcs), “Across the Great Divide: The Upstream Origins & Downstream Ramifications of a Newly Discovered Contaminant Class”

Oct7-11: 41th ESMO European Cancer Congress, Copenhagen, Denmark http://tinyurl.com/jxdppyo (Oral Pres. of Topline Data from Ph3 SUNRISE trial, incl. initial Biomarker analysis)
...10-10-16 9:15-9:30am: David R. Spigel (CSO/Dir./Sarah Cannon Res. Inst., Nashville) Proffered Oral Presentation, “Top-line Results from Ph3/SUNRISE..." (Senior-Author: David Gerber/UTSW)
......10-10-16 ESMO’16 Topline/Ph3.SUNRISE Data: Biomarker B2GPI/200-240(30%pts) StatSig OS 7.7=>13.2mos. http://tinyurl.com/hp73njt
...10-9-16 1:00-2:00pm: Jeff Hutchins(VP/PreClin.Res), “Antibody Mediated Blockade of PS Improves Immune Checkpoint Blockade...”

Oct13/10am: Annual SHM, Avenue of the Arts Hotel, Costa Mesa – Final Proxy: http://tinyurl.com/gsrmgs2 - ATTENDEE Reports: http://tinyurl.com/jx7ouay

Oct22: AACR’s Tumor Immunotherapy Conf./Boston http://tinyurl.com/zzryfok - Duke’s Herbert K. Lyerly (w/PPHM) poster on AntiPS/TNBC data: ”Modulating The Tumor Microenvironment to Enhance Cancer Immunotherapy by Inducing PS Expression on the Tumor Surface”

Nov9-13: (SITC) Society for Immunotherapy of Cancer 31st Annual Meeting, Natl-Harbor MD => See posters & Dr. Wolchok's comments: http://tinyurl.com/js3fca4
...”First Results” from our collaboration with Jedd Wolchok Lab investigators (Memorial Sloan Kettering) to be presented” (per 9-8-16/Ccall/Hutchins)
...I. Nov11 12:15-1:30pm: “PS Targeting Antibody in Combo w/Checkpoint Blockade & Tumor Rad. Therapy Promotes Anti-Cancer Activity in Mouse Melanoma” - Sadna Budhu, PhD - Ludwig Collaborative Lab, MSKCC
...II. Nov12 11:45-1pm: “Antibody Targeting of PS Enhances the Anti-Tumor Responses of Ibrutinib & anti-Pd-1 Therapy in a Mouse Triple Neg. Breast Tumor Model” - Jian Gong, PhD, PPHM
...III. Nov11 12:15-1:30pm: "Mabs Targeting PS Enhance Combinational Activity of the the Immune Checkpoint Targeting Agents LAG3 & PD-1 in Murine Breast Tumors” - Michael Gray, PhD, PPHM

[cheynew]

Here are the upcoming events this months thanks to CJ. More detail in his referenced post I am responding to. There is a 6 hour difference between Vienna and the East Coast USA.

Dec7: WCLC’16 - IASLC’s 17th World Conf. on Lung Cancer, Vienna, Austria http://tinyurl.com/z8cq8vx
…2:30-3:45pm UTSW’s Dr. David Gerber to present addl. Biomarker data from Ph3.SUNRISE Trial: “A Pre-Treatment Serum Test Based on Complement & IL-10 Pathways Identifies Patients Benefiting from the Addition of Bavituximab to Docetaxel”
Dec8: 39th San Antonio Breast Cancer Symposium” http://tinyurl.com/zb5sopc
...Dr. Bruce Freimark(Dir.Res/Preclin.Oncology) poster: “PS-Targeting Enhances Anti-LAG3 in Murine Breast Cancer Tumors”
Dec12: FY'17Q2 (qe 10-31-16) Financials & Conf. Call - http://ir.peregrineinc.com/events.cfm
Dec11-15/Avid/Booth#209: IBC's Antibody Eng. & Therapeutics 2016”, SanDiego http://www.ibclifesciences.com/AntibodyEng/overview.xml